Approval · Notice of Compliance 14896 · 2013
ESTRUMATE: Notice of Compliance 14896
Issued November 12, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14896
- Date
- November 12, 2013
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Prostaglandin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRUMATE | 02137658 | Marketed |
Medicinal ingredients
- CLOPROSTENOL SODIUM 250 MCG per ML